News and Releases
US Medical Innovations Raises $10.2 M in Private Placement
JCRI – ABTS and USMI to Present a Two-year Follow-up of Phase I Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Solid Tumors at Israeli Society of Surgical Oncology
JCRI DISCOVERS REGULATORY GENE BCL2A1 FOR TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
USMI and JCRI Research Teams Develop Treatment System for COVID and other Respiratory Infections and Diseases
USMI to Announce Successful Results of Phase I Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Solid Tumors at the Baird 2021 Global Healthcare Conference
JCRI Discovers the Mechanism using Canady Helios™ Cold Plasma to Induce Cell Death in Breast Cancer
USMI Developing the First Surgical Robot for Cancer Surgery
JCRI-ABTS and USMI Successfully Use Canady Helios™ Cold Plasma in Combination with FOLFIRINOX for the Treatment of Cholangiocarcinoma
JCRI-ABTS and USMI Successfully Complete Phase 1 Multi-Center Clinical Trial Using Canady Helios™ Cold Plasma for the Treatment of Cancer
Rush Cancer Surgeons Perform Country’s First Cold Plasma Adjuvant Therapy
Canady Cold Atmospheric Plasma Provides New Insight for the Potential Treatment of Breast Cancer
JCRI-ABTS Seeks FDA Emergency Use Authorization for the Canady Helios Cold Plasma HERO System for the Treatment of COVID-19
Canady Helios Cold Plasma Scalpel Successfully Used by Chaim Sheba Medical Center Surgeons to Remove Inoperable Retroperitoneal Cancer
US Patent Office Issues Decision to Grant Patent for USMI’s Cold Atmospheric Plasma for the Selective Ablation of Cancer Cells
USMI announced today that the United States Patent Office (USPO) has issued USPI patent No. 10,023,858 B2, further expanding its intellectual patent property portfolio for the application of delivering Cold Atmospheric Plasma (CAP) technology to selectively target cancer cells.
Takoma Park, MD
Jerome Canady, M.D. Invited Speaker: The Evolution of Plasma Energy ACS Session: Energy Sources in Surgery: How to Improve Efficacy Congresso Congiunto 2018 Society of Italian Surgeons
Roma Convention Center La Nuvola Rome, Italy
October 14 -18, 2018
US Patent Office Issues Patent for USMI’s Cold Atmospheric Plasma for the Treatment of Cancer
USMI is the first company in the world to integrate a high frequency electrosurgical generator and plasma gas to deliver a Cold Atmospheric Plasma (CAP) for the selective treatment of cancer.
Takoma Park, MD
Electric Discharge During Electrosurgery
USMI receives Federal Supply Schedule Contract Approval.
Effective August 1st, 2015, the full line of US Medical Innovations products have been added to Veterans Healthcare Supply Solutions, Inc., FSS V797D-40049. Veterans Healthcare Supply Solutions, Inc., is a verified Service Disabled Veterans Owned Small Business.